Pharmacokinetics and Bioequivalence of Three Nizatidine Preparations in Healthy Chinese Volunteers

Songqin Liu
2008-01-01
Abstract:Objective:To evaluate the pharmacokinetics and bioequivalence of nizatidine tablets and capsules(test samples) with nizatidine tablets(reference samples) in the healthy volunteers.Methods:This was an open randomized,three periods cross over study that recruited eighteen healthy male volunteers.Each volunteer was randomly administered with a single oral dose of nizatidine(test or reference samples) 150 mg.The plasma concentrations of nizatidine were determined by HPLC.Non-compartment models was used in analysis of pharmacokinetic parameters.Logarithm-transformed Cmax and AUC were analyzed by the analysis of variance(ANOVA) and 90% confidence intervals.Results:The Cmax of test nizatidine tablets,capsules and reference tablets were(1 280 ± 359),(1 377 ± 438) and(1 140 ± 269) ng · mL-1,respectively.tmax were(0.986 ± 0.358),(1.069 ± 0.362) and(1.125 ± 0.464) h,respectively.t1/2 were(1.556 ± 0.312),(1.441 ± 0.309) and(1.511 ± 0.259) h,respectively;AUC0-t were(3 864.50 ± 662.77),(3 775.06 ± 596.18) and(3 685.83 ± 561.46) ng · h · mL-1,respectively.AUC0-∞ were(3 896.55 ± 668.89),(3 798.17 ± 605.86) and(3 711.37 ± 563.63) ng · h · mL-1,respectively.Conclusion:The test nizatidine tablets and capsules are bioequivalent with the reference tablets.
What problem does this paper attempt to address?